Skip to main content
. 2021 Mar 5;70(10):2851–2865. doi: 10.1007/s00262-021-02895-7

Fig. 1.

Fig. 1

CD19 and CD46 expression in lymphoma cell lines and viability post LOAd infection. Human lymphoma cell lines (BC-3, Karpas422, Daudi, DG-75 and U-698) were analyzed for CD19 and CD46 expression by flow cytometry. Filled gray histograms display isotype control staining and overlaid black lines show CD19 (a) and CD46 expression (b). Lymphoma cells were infected with LOAd viruses or replication-deficient Ad5/35 Mock virus at different virus to cell ratios (10, 50, 100 and 200 MOI). Cell viability was analyzed with MTS viability assay 96 h post infection (c) and over an extended time period (72–144 h) for cells infected with 200 MOI (d). Viability is shown as percentage viability of uninfected control cells (mean ± SD of technical quadruplicates; representative of two independent experiments). Statistical differences compared to uninfected control cells were analyzed at 200 MOI (c) or 144 h (d) with one-way ANOVA followed by Dunnett’s multiple comparisons test (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)